Cite
HARVARD Citation
Clowry, J. et al. (2017). Increased non‐melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single‐centre cohort study. Journal of the European Academy of Dermatology and Venereology. pp. 978-985. [Online].